GlassScriptPhysician profile
Marshall L Stoller
NPI 1104854512
$290,062.01
in general payments reported to CMS, 2019-2025
13 companies · $697 in 2025
The $697 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215K · 2020: $38K · 2021: $12K · 2022: $6,819 · 2023: $3,121 · 2024: $13K · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $2,066 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,012 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,867.50 |
| Food and Beverage | $2,066.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,012.00 |
| Travel and Lodging | $325.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $264,183.26 | 2019-2021 | |
| Novo Nordisk INC | $10,802.93 | 2022-2025 | Rivfloza |
| Otu Medical INC. | $10,000.00 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $2,224.97 | 2019-2025 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Boston Scientific Corporation | $1,916.46 | 2019-2025 | Lithovue, General - Kidney Stone Disease |
| Hitachi Healthcare Americas Corp. | $248.13 | 2019 | |
| Karl Storz Endoscopy-America | $212.13 | 2022-2023 | Hd-View |
| Urogen Pharma, INC. | $197.27 | 2023-2024 | Jelmyto |
| Novo Nordisk Health Care Ag | $124.00 | 2024 | |
| Cook Medical LLC | $114.28 | 2025 | Litho 150 |
| Coloplast Corp | $38.58 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.